Promises
3 promises
Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →
Galaxy Surfactants Limited — Q4 FY26
Galaxy Surfactants reported Q4 FY26 EBITDA of ₹122 crore, down ~10% YoY, impacted by West Asia war disruptions, raw material inflation, and logistics bottlenecks.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Galaxy Surfactants reported Q4 FY26 EBITDA of ₹122 crore, down ~10% YoY, impacted by West Asia war disruptions, raw material inflation, and logistics bottlenecks. India volumes grew 8% YoY driven by specialty (+27% YoY) and D2C accounts, while AMET volumes fell 15% due to supply constraints. The US business showed recovery post tariff reversals, with specialty pipeline reinitiated. Management guided Q1 FY27 volume growth at the higher end of 6-8% and EBITDA per metric ton at ₹19,000-21,000, contingent on stable geopolitics. Key risks include demand destruction from energy-driven inflation and potential grammage cuts by customers. The company remains confident of sequential improvement but refrained from full-year guidance due to uncertainty.
गैलेक्सी सर्फेक्टेंट्स ने चौथी तिमाही में 122 करोड़ रुपये का EBITDA कमाया, जो पिछले साल से 10% कम है। इसकी वजह पश्चिम एशिया युद्ध, कच्चे माल की बढ़ती कीमतें और आपूर्ति में रुकावटें हैं। भारत में बिक्री 8% बढ़ी, खासकर स्पेशियलिटी उत्पादों (27% बढ़ोतरी) और सीधे ग्राहकों को बेचने से। वहीं, AMET क्षेत्र में आपूर्ति कम होने से बिक्री 15% गिर गई। अमेरिका में टैरिफ हटने के बाद सुधार दिख रहा है। कंपनी को अगली तिमाही में 6-8% बिक्री बढ़ने और प्रति टन 19,000-21,000 रुपये EBITDA की उम्मीद है, लेकिन यह भू-राजनीतिक स्थिरता पर निर्भर करेगा। जोखिमों में महंगाई से मांग कम होना और ग्राहकों का पैकेजिंग कम करना शामिल है। कंपनी ने पूरे साल का अनुमान नहीं दिया।
Promises0 met · 3 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Demand destruction from energy-driven inflation
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
India Volume Growth
8%
+8% YoY
India volumes grew 8% YoY in Q4, driven by 27% growth in specialty and strong D2C account performance.
AMET Volume Decline
-15%
-15% YoY
AMET region volumes declined 15% YoY due to supply chain disruptions from West Asia war and raw material availability.
Specialty Volume Growth (India)
27%
+27% YoY
Specialty volumes in India grew 27% on an annual basis, consistent with Strategy 2030.
EBITDA per Metric Ton (Q4)
₹20,114
-₹1,601 YoY
EBITDA per metric ton declined to ₹20,114 from ₹21,715 in Q4 FY25, impacted by raw material cost inflation.
What Changed vs Last Quarter
NEW
Q1 FY27 volume growth at higher end of 6-8%
Management expects Q1 FY27 volume growth to be at the higher end of the 6-8% range, driven by India recovery, US revival, and AMET supply normalization.
NEW
Q1 FY27 EBITDA per metric ton at higher end of ₹19,000-21,000
EBITDA per metric ton for Q1 FY27 is expected at the higher end of the ₹19,000-21,000 range, supported by volume growth and mix improvement.
NEW
India volume growth of 8-10% possible if demand holds
India could return to 8-10% volume growth if monsoon and energy prices do not impact demand, but management remains cautious.
NEW
No new growth capex in FY27
Management indicated no new growth capex commitments for FY27 beyond capitalizing work-in-progress and routine replacement capacities.
DROPPED
India specialty volume growth to remain double-digit
Management expects double-digit volume growth in the specialty segment in India, supported by new product launches and customer approvals.
DROPPED
New reformulation products to commercialize in Q4 FY26
Alternate formulations for key tier-1 customers are under approval and expected to start commercialization in Q4 FY26.
DROPPED
US specialty pipeline projects to restart from late Q4
With tariff reduction, customer projects put on hold are expected to resume, contributing from late Q4 FY26 and Q1 FY27.
DROPPED
Fatty alcohol prices expected to correct from May 2026
Management expects fatty alcohol prices to start correcting from May onwards due to seasonal palm production increases.
NEW RISK
Demand destruction from energy-driven inflation
Rising energy prices could reduce consumer discretionary spending, impacting demand for Galaxy's products, especially in India and export markets.
NEW RISK
Grammage cuts by customers
Customers may reduce product grammage to pass on price increases, indirectly pressuring Galaxy's volume growth beyond Q1.
NEW RISK
Supply chain disruptions from West Asia war
Continued geopolitical tensions could prolong logistics delays and raw material shortages, affecting production and dispatches.
NEW RISK
AMET region structural demand weakness
AMET markets face prolonged demand recession due to inflation and currency issues, with recovery expected to be gradual.
RISK GONE
Sustained high fatty alcohol prices
Fatty alcohol prices remain elevated, prolonging reformulation pressures and delaying volume recovery in India.
RISK GONE
US demand slowdown flagged by key customers
Key US customers have flagged demand concerns in beauty and wellbeing, which could temper specialty volume recovery despite tariff relief.
RISK GONE
AMET market share loss may be permanent
Management acknowledged that peak volumes in AMET are unlikely to return due to backward-integrated local competitors and currency depreciation in Egypt.
RISK GONE
EPC project contribution not significant
The EPC project with a US customer provides only modest income and is not expected to materially impact earnings.
Fast read
Guidance and risk preview
Management expects Q1 FY27 volume growth to be at the higher end of the 6-8% range, driven by India recovery, US revival, and AMET supply normaliza...
Rising energy prices could reduce consumer discretionary spending, impacting demand for Galaxy's products, especially in India and export markets.
View Risks →